Rapport Therapeutics, Inc.
RAPP • NASDAQ
Rapport Therapeutics, Inc. is a publicly traded company trading on NASDAQ, led by CEO Abraham N. Ceesay, with a market cap of $1.3B.
CEOAbraham N. Ceesay
Market Cap$1.3B
Websiterapportrx.com
Next Earnings
Upcoming earnings announcement for Rapport Therapeutics, Inc.
Date
Thursday, May 7, 2026 (in a month)
Timing
Before Market Open (6:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.62
Revenue Estimate
$12.0M
Earnings History
Past 7 earnings reports for Rapport Therapeutics, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 10, 2026 | Q4 2025 | -$0.72Est: -$0.66 | -9.1% | - | — |  10-K |
| Nov 6, 2025 | Q3 2025 | -$0.71Est: -$0.75 | +5.3% | - | — | 10-Q |
| Aug 7, 2025 | Q2 2025 | -$0.75Est: -$0.82 | +8.5% | - | — | 10-Q |
| May 8, 2025 | Q1 2025 | -$0.68Est: -$0.75 | +9.3% | - | — | 10-Q |
| Mar 11, 2025 | Q4 2024 | -$0.57Est: -$0.61 | +6.6% | - | — | 10-K |
| Nov 7, 2024 | Q3 2024 | -$0.50Est: -$0.57 | +12.3% | - | — | 10-Q |
| Aug 8, 2024 | Q2 2024 | -$1.70Est: -$0.67 | -153.7% | - | — | 10-Q |